16
2
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T39986 |
LOX-IN-3 dihydrochloride
|
Lipoxygenase | Metabolism |
LOX-IN-3 dihydrochloride 是口服有效的赖氨酰氧化酶抑制剂,在纤维化,癌症和/或血管生成方面有研究价值。 | |||
T12584 |
PXS-5120A
|
Others; Monoamine Oxidase | Neuroscience; Others |
PXS-5120A 是一种不可逆的 Lysyl Oxidase-like 2/3 (LOXL2/3) 的氟代烯丙胺抑制剂,具有抗纤维化活性。 | |||
T12585 |
PXS-5153A
|
Others; Monoamine Oxidase | Neuroscience; Others |
PXS-5153A 是一种有效、特异性和速效的Lysyl Oxidase-like 2/3 (LOXL2/3) 抑制剂,其酶活性在 15 分钟内几乎完全阻断。 PXS-5153A 可以减少交联并改善纤维化。 | |||
T26969 |
CCT365623
CCT-365623,CCT 365623 |
Monoamine Oxidase | Neuroscience |
CCT365623 是一种口服生物可利用的赖氨酰氧化酶抑制剂,具有良好的抗 LOX 效力、选择性、药代动力学特性以及抗转移功效。 | |||
T20533 |
NNK
Nicotine-derived nitrosamine ketone |
Lipoxygenase | Metabolism |
NNK (Nicotine-derived nitrosamine ketone) 是尼古丁亚硝化衍生物。它可以激活 ERK1/2和 PKCα,并在 Ser70 激活 Bcl2磷酸化,以及在 Thr58和 Ser62激活 c-Myc。它可用于构建肺癌小鼠模型,以及诱导人肺癌细胞的增殖和存活。 | |||
T69913 |
Lenumlostat
PAT-1251,GB2064 |
Monoamine Oxidase | Neuroscience |
Lenumlostat 是一种可口服且具有选择性和有效性的赖氨酰氧化酶样蛋白 2 (LOXL2) 抑制剂,对 hLOXL2 、 hLOXL3 和 LOXL2 具有抑制作用,可用于研究纤维性疾病。 | |||
T76700 |
Simtuzumab
GS 6624,AB 0024 |
Monoamine Oxidase | Neuroscience |
Simtuzumab 是一种针对赖氨酰氧化酶样蛋白 2 (LOXL2) 的单克隆抗体。Simtuzumab 可用于治疗原发性硬化性胆管炎 (PSC),对非酒精性脂肪性肝炎引起的桥接性纤维化或代偿性肝硬化患者无效 。 | |||
T12371 |
PAT-1251 Hydrochloride
|
Others | Others |
PAT-1251 Hydrochloride is a potent, selective and oral inhibitor of lysyl oxidase-like 2 (LOXL2)(hLOXL2 and hLOXL3 with IC50s of 0.71 and 1.17 μM , respectively), | |||
T38294 |
4-Deoxypyridoxine hydrochloride
|
S1P Receptor | GPCR/G Protein |
4-Deoxypyridoxine hydrochloride 通过抑制 S1P 裂解酶 (SPL) 活性来抑制细胞内 S1P 的降解,与 S1P 一样,减少化学诱导的胰岛素瘤细胞系的细胞凋亡。 | |||
T10719 |
CCT365623 hydrochloride
|
Lipoxygenase | Metabolism |
CCT365623 hydrochloride is an orally active inhibitor of lysyl oxidase (LOX) (IC50: 0.89 μM). It suppresses EGFR (pY1068) and AKT phosphorylation driven by EGF. | |||
T60296 | PXS-4787 | ||
PXS-4787 is a potent and selective inhibitor of lysyl oxidase (LOX) with broad-spectrum activity. It effectively suppresses lysyl oxidase activity by acting on its mechanisms. The compound displays inhibitory effects with IC50 values of 2 μM (Bovine LOX), 3.2 μM (rh LOXL1), 0.6 μM (rh LOXL2), 1.4 μM (rh LOXL3), and 0.2 μM (rh LOXL4), respectively [1]. | |||
T38006 |
LOX-IN-3
|
||
LOX-IN-3, an orally active inhibitor of lysyl oxidase (LOX), holds potential application in the fields of fibrosis, cancer, and angiogenesis research[1]. | |||
T61479 |
LOX-IN-3 dihydrochloride monohydrate
|
||
LOX-IN-3 dihydrochloride monohydrate (Compound 33) is a lysyl oxidase (LOX) inhibitor with oral activity. It is specifically designed for research purposes in the areas of fibrosis, cancer, and angiogenesis [1]. | |||
T72103 |
β-Aminopropionitrile hydrochloride
BAPN hydrochloride |
||
β-Aminopropionitrile (BAPN) hydrochloride 是一特异性、不可逆性、口服活性的氨酰氧化酶 (LOX) 抑制剂,针对 LOX 或 LOXL 同工酶活性位点。 | |||
T12585L |
PXS-5153A monohydrochloride
PXS-5153A monohydrochloride (2125956-82-1 free base) |
Others | Others |
PXS-5153A monohydrochloride 是一种有效的、选择性的、具有口服活性和快速起效的赖氨酰氧化酶 2/3(LOXL2/LOXL3)的双抑制剂,对几乎所有哺乳动物物种 LOXL2的 IC50均< 40 nM,对人类 LOXL3 的 IC50为63 nM。PXS-5153A monohydrochloride 可减少交联并改善纤维化。 | |||
T60438 |
PXS-6302
|
||
PXS-6302 是不可逆的赖氨酸氧化酶 (LOX) 抑制剂,对Bovine LOX、rh LOXL1、rh LOXL2、rh LOXL3、rh LOXL4的IC50分别为 3.7 μM,3.4 μM,0.4 μM,1.5 μM 和0.3 μM。PXS-6302 可以轻松渗透皮肤,减少胶原蛋白沉积和交联,显着改善疤痕外观而不降低组织强度。 PXS-6302 在其他纤维化疾病中也可能有更广泛的应用。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T13475 |
β-Aminopropionitrile
3-氨基丙腈,3-Aminopropionitrile,BAPN |
Others; Endogenous Metabolite | Metabolism; Others |
β-Aminopropionitrile (3-Aminopropionitrile) 是赖氨酰氧化酶的特异性抑制剂。 | |||
T20852 | Triamcinolone diacetate | ||
Triamcinolone diacetate is an antagonist of Lysyl oxidase. |